<DOC>
	<DOCNO>NCT02655146</DOCNO>
	<brief_summary>The aim present prospective randomize control study determine effect GnRHa add routine luteal phase support frozen embryo implantation frozen embryo transfer ( FET ) .</brief_summary>
	<brief_title>Effects GnRHa Add Routine Luteal Phase Support Frozen Embryo Implantation Frozen Embryo Transfer .</brief_title>
	<detailed_description>Some recent data suggest beneficial effect GnRHa administer luteal phase outcome assist reproduction technique . In study , dose administration time GnRHa inconsistent . Single administration third day embryo transfer multiple dose injection luteal phase common way . The GnRHa include Triptorelin 0.1mg , Leuprorelin 1mg Buserelin 600ug et al . The exact underlying mechanism still clear , although hypothesize GnRH agonist either support corpus luteum function induce LH secretion pituitary gonadotrophin cell stimulate endometrium GnRH receptor . Tesarik et al.postulated direct effect GnRH agonist embryo , evidence increase Î²-HCG secretion . Currently , available data suggest inadvertent administration GnRH agonist conception cycle accompany increase risk birth defect . On basis currently strong available evidence , appear GnRH agonist supplementation luteal phase significantly improve outcome ART treatment . Most former research focus fresh embryo transfer IVF/ICSI cycle . In one prospective control study , single dose Triptorelin 0.1mg administrate 6 day ICSI oocyte donor cycle implantation rate improve significantly.GnRH agonist administration time implantation enhances embryo developmental potential , probably direct effect embryo .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Triptorelin Pamoate</mesh_term>
	<mesh_term>Estradiol valerate</mesh_term>
	<mesh_term>Estradiol 3-benzoate</mesh_term>
	<mesh_term>Estradiol 17 beta-cypionate</mesh_term>
	<mesh_term>Progesterone</mesh_term>
	<mesh_term>Estradiol</mesh_term>
	<mesh_term>Polyestradiol phosphate</mesh_term>
	<criteria>infertile woman freeze thaw embryo transfer HRT endometrial preparation . 20 year old , less 37 year old . BMI le 28kg/m2 . 1 transplantable embryo thaw . patient sign informed consent willing follow . uterine malformation diameter intramural myoma 3cm thickness endometrium le 7mm progesterone supportive day .</criteria>
	<gender>Female</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>37 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Frozen embryo transfer , luteal support , GnRHa</keyword>
</DOC>